Roncarolo MG - Search Results

1

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.

Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Battaglia M, et al. Among authors: roncarolo mg. J Immunol. 2006 Dec 15;177(12):8338-47. doi: 10.4049/jimmunol.177.12.8338. J Immunol. 2006. PMID: 17142730

2

STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.

Passerini L, Allan SE, Battaglia M, Di Nunzio S, Alstad AN, Levings MK, Roncarolo MG, Bacchetta R. Passerini L, et al. Among authors: roncarolo mg. Int Immunol. 2008 Mar;20(3):421-31. doi: 10.1093/intimm/dxn002. Epub 2008 Feb 12. Int Immunol. 2008. PMID: 18270368

3

The role of cytokines (and not only) in inducing and expanding T regulatory type 1 cells.

Battaglia M, Roncarolo MG. Battaglia M, et al. Among authors: roncarolo mg. Transplantation. 2004 Jan 15;77(1 Suppl):S16-8. doi: 10.1097/01.TP.0000106468.96542.26. Transplantation. 2004. PMID: 14726763 Review.

4

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

Battaglia M, Stabilini A, Roncarolo MG. Battaglia M, et al. Among authors: roncarolo mg. Blood. 2005 Jun 15;105(12):4743-8. doi: 10.1182/blood-2004-10-3932. Epub 2005 Mar 3. Blood. 2005. PMID: 15746082 Free article.

5

Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.

Battaglia M, Stabilini A, Draghici E, Gregori S, Mocchetti C, Bonifacio E, Roncarolo MG. Battaglia M, et al. Among authors: roncarolo mg. Diabetes. 2006 Jan;55(1):40-9. Diabetes. 2006. PMID: 16380475

6

Tr1 cells: from discovery to their clinical application.

Battaglia M, Gregori S, Bacchetta R, Roncarolo MG. Battaglia M, et al. Among authors: roncarolo mg. Semin Immunol. 2006 Apr;18(2):120-7. doi: 10.1016/j.smim.2006.01.007. Epub 2006 Feb 7. Semin Immunol. 2006. PMID: 16464609 Review.

7

Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells.

Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, Bonifacio E, Roncarolo MG. Battaglia M, et al. Among authors: roncarolo mg. Diabetes. 2006 Jun;55(6):1571-80. doi: 10.2337/db05-1576. Diabetes. 2006. PMID: 16731819

8

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

Roncarolo MG, Battaglia M. Roncarolo MG, et al. Nat Rev Immunol. 2007 Aug;7(8):585-98. doi: 10.1038/nri2138. Nat Rev Immunol. 2007. PMID: 17653126 Review.

9

Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells.

Monti P, Scirpoli M, Maffi P, Piemonti L, Secchi A, Bonifacio E, Roncarolo MG, Battaglia M. Monti P, et al. Among authors: roncarolo mg. Diabetes. 2008 Sep;57(9):2341-7. doi: 10.2337/db08-0138. Epub 2008 Jun 16. Diabetes. 2008. PMID: 18559659 Free PMC article. Clinical Trial.

10

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Gregori S, Battaglia M, Roncarolo MG. Gregori S, et al. Among authors: roncarolo mg. Novartis Found Symp. 2008;292:174-83; discussion 183-6, 202-3. doi: 10.1002/9780470697405.ch16. Novartis Found Symp. 2008. PMID: 19203099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters